Explore cutting-edge studies in tumor biology, molecular pathways, and clinical breakthroughs
Groundbreaking research on decorin protein's potential to reverse trabecular meshwork fibrosis in open-angle glaucoma, offering hope for millions affected by this leading cause of blindness.